DIABETES WEARABLES FOR GAMERS
17th February 2022
Nintendo® video game Animal Crossing™: New Horizons have today made it possible for players to download design codes to access custom outfits that let them wear an insulin pump or carry an accessory bag for their diabetes supplies. They can also visit Omnipod Bay, a family-friendly, diabetes-themed island full of adventures, surprises, and experiences which include booths promoting awareness for advocacy organizations like JDRF, Beyond Type 1, Children with Diabetes, and Kyler Cares Foundation.
In addition to selecting one of the outfits, players can visit Omnipod Bay to navigate an obstacle maze, take part in a scavenger hunt, perform in a concert, swim in the A1 Sea (a play on A1c, also known as HbA1c or haemoglobin A1c, which is your average blood sugar levels over the past 3 months), discover a hidden lounge, or snap selfies at one of the other community-inspired sites sprinkled throughout the island.
Full press release: click here
WORLD'S FASTEST MARATHON RUNNER WITH LIBRE
8th February 2022
Did you see this picture today? It's the world's fastest marathon runner, Eliud Kipchoge, wearing a Libre Sense. Abbott have released details of how he's teaming up with them to develop the side of the business for athletes.
If you think athletes are muscling in on PWD tech read our article here https://lovemylibre.com/blogs/news/libre-sense-vs-freestyle-sports-tech-muscling-diabetes-care
(originally posted October 2020)
Press release from Abbott:
NEW IMPLANTABLE CGM THAT CAN LAST 6 MONTHS
11th February 2022
Senseonics have been given approval in the US for the first long-term implantable CGM system, the next-generation Eversense® E3 CGM System provides up to 6 months use.
Press release from Senseonics here:
Find out more about CGM products from Senseonics here:
CGM IS BETTER THAN FINGER-PRICKS
Updated 11th February 2022
A report in the March 2022 edition of Diabetologia (for healthcare professionals) highlights the benefits of type 1s using a CGM over regular finger prick tests. Perhaps something we, as members of the type 1 community know, but there are still other parties that haven't yet taken the evidence on board.
In particular the report shows that type 1s with an HbA1c over 64 mmol/mol (that's 8%) are more likely to benefit from continuous glucose monitors than traditional testing techniques. Data was collated from over 2,000 persons with type one diabetes.
Read the report here:
REAL-TIME CGM IS COMING FOR ALL T1Ds in ENGLAND
Updated 11th February 2022
To confirm, the changes to NICE Guideline NG17 coming into place in April 2022, according to Partha Kar, NHS Speciality Advisor for Diabetes:
PREVIOUS MONTHS' NEWS
Read January News: Click here.